tirzepatide cvot Long-awaited SURPASS-CVOT: Cardiovascular Outcomes with vs Dulaglutide in NEJM: #tirzepatide noninferior to #dulaglutide for 3-point MACE in T2D with ASCVD, with greater improvements in weight, A1c, BP, triglycerides, and kidney function Cardiovascular effects of tirzepatide -

yes yes Your review * I have not tried this but I really want to I need to loose 75 pounfd Great pricing, easy to use Great price and awesome product

Jardiance may be favored when SGLT2-related heart or kidney benefits are central

Important considerations before switching GLP-1 therapy The following are important considerations before switching GLP-1 medications: Oral vs

Both medications have a black box warning from the FDA for the risk of thyroid C-cell tumors

Because of this, providers monitor patients with risk factors

Ozempic tablets should not be used by people with a personal or family history of medullary thyroid carcinoma or by those with Multiple Endocrine Neoplasia syndrome type 2